N/A Completed N=20 Treatment

Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females

androgenetic alopecia

Source: ClinicalTrials.gov NCT01701271 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Feb 2016

Primary outcomePrimary: Change of the Amount of Hair Loss in a Pull Test — 2.75 Fallen hair

Summary

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change of the Amount of Hair Loss in a Pull Test	2.75	—
PRIMARY Change of the Density of the Hair on a Polarized Light Video-camera as a Measure of Efficacy.	2.75	—
SECONDARY Change of Sebum on a Sebum-meter	8.8	—

Eligibility Criteria

Inclusion Criteria

Good state of general health
Suffering from hair loss
No pharmacological treatment in progress
Promise not to change the usual daily routine
No atopy in the anamnesis

Exclusion Criteria

Illness
Good state of hair
Pharmacological treatment in progress
Denial of the continuance of the usual daily routine
Atopy in the anamnesis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01701271). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.